Searching News Database: Endeavor
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 31 Jan 2025
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
HSMN NewsFeed - 23 May 2024
SystImmune, Inc. Announces the Appointment of Dr. Jonathan Cheng as New Chief Medical Officer
SystImmune, Inc. Announces the Appointment of Dr. Jonathan Cheng as New Chief Medical Officer
HSMN NewsFeed - 24 Apr 2024
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
HSMN NewsFeed - 26 Feb 2024
Study Using IceCure's ProSense(R) Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer
Study Using IceCure's ProSense(R) Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer
HSMN NewsFeed - 15 Feb 2024
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer
HSMN NewsFeed - 15 Aug 2023
Vertos Medical Promotes Two Senior Leaders to Newly Created C-Suite Roles
Vertos Medical Promotes Two Senior Leaders to Newly Created C-Suite Roles
HSMN NewsFeed - 23 Jun 2023
Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors
Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors
HSMN NewsFeed - 6 Jul 2022
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén
HSMN NewsFeed - 18 Mar 2022
Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system
Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system
HSMN NewsFeed - 29 Dec 2021
Ionis and AstraZeneca close deal to develop and commercialize eplontersen
Ionis and AstraZeneca close deal to develop and commercialize eplontersen
HSMN NewsFeed - 27 Dec 2021
VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D
VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D
HSMN NewsFeed - 3 Dec 2021
Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer
Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer
HSMN NewsFeed - 24 Nov 2021
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
HSMN NewsFeed - 4 Nov 2021
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
HSMN NewsFeed - 15 Apr 2021
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
HSMN NewsFeed - 5 Apr 2021
Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS
Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS
HSMN NewsFeed - 19 Mar 2021
Zimmer Biomet Expands Role for Ivan Tornos, Appointing Him to New Chief Operating Officer Post
Zimmer Biomet Expands Role for Ivan Tornos, Appointing Him to New Chief Operating Officer Post
HSMN NewsFeed - 12 Nov 2020
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
HSMN NewsFeed - 3 Nov 2020
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
HSMN NewsFeed - 8 Sep 2020
FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer
FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer
HSMN NewsFeed - 9 Jun 2020
Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy
Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy
HSMN NewsFeed - 30 Mar 2020
MIVI Neuroscience Promotes Bob Colloton to CEO and Appoints Robert Stern to Board of Directors
MIVI Neuroscience Promotes Bob Colloton to CEO and Appoints Robert Stern to Board of Directors
HSMN NewsFeed - 14 Feb 2020
Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations
Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations
HSMN NewsFeed - 13 Feb 2020
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
HSMN NewsFeed - 20 Jan 2020
Venus Medtech Announces the Addition of Two Cardiovascular Experts to Their Advisory Team
Venus Medtech Announces the Addition of Two Cardiovascular Experts to Their Advisory Team
HSMN NewsFeed - 30 Oct 2019
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
HSMN NewsFeed - 4 Jan 2019
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
HSMN NewsFeed - 13 Dec 2018
Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer
Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer
HSMN NewsFeed - 5 Sep 2018
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
HSMN NewsFeed - 20 Mar 2018
Bionik Laboratories Appoints Peter Gerald Malone and Joseph Martin to its Board of Directors
Bionik Laboratories Appoints Peter Gerald Malone and Joseph Martin to its Board of Directors
HSMN NewsFeed - 15 Feb 2018
Viz.ai Granted De Novo FDA Clearance for First Artificial Intelligence Triage Software
Viz.ai Granted De Novo FDA Clearance for First Artificial Intelligence Triage Software
HSMN NewsFeed - 22 Jan 2018
Titan In Discussions With Braeburn Regarding U.S. Probuphine(R) Commercialization
Titan In Discussions With Braeburn Regarding U.S. Probuphine(R) Commercialization
HSMN NewsFeed - 9 Nov 2017
Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
HSMN NewsFeed - 28 Mar 2017
ONL Therapeutics Strengthens Leadership with Addition to Board of Directors and Expansion of Operations Team
ONL Therapeutics Strengthens Leadership with Addition to Board of Directors and Expansion of Operations Team
HSMN NewsFeed - 26 Dec 2016
SPINRAZA(TM) (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy
SPINRAZA(TM) (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy
HSMN NewsFeed - 14 Oct 2016
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y(TM) Dosimetry Software in Europe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y(TM) Dosimetry Software in Europe
HSMN NewsFeed - 1 Aug 2016
Sorrento Therapeutics Announces the Appointment of Dr. Yue Alexander Wu to its Board of Directors
Sorrento Therapeutics Announces the Appointment of Dr. Yue Alexander Wu to its Board of Directors
HSMN NewsFeed - 14 Jun 2016
Ability Dynamics, LLC. announces Distribution Partnership With Korean-Based Sunglim Trading Co.
Ability Dynamics, LLC. announces Distribution Partnership With Korean-Based Sunglim Trading Co.
HSMN NewsFeed - 1 Apr 2016
BTG Announces US Launch of LC Bead LUMI(TM), Ground-Breaking Radiopaque Embolic Bead
BTG Announces US Launch of LC Bead LUMI(TM), Ground-Breaking Radiopaque Embolic Bead
HSMN NewsFeed - 24 Mar 2016
Juniper Pharmaceuticals Appoints Mary Ann Gray, Ph.D., to Board of Directors
Juniper Pharmaceuticals Appoints Mary Ann Gray, Ph.D., to Board of Directors
HSMN NewsFeed - 7 Mar 2016
Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer
Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer
HSMN NewsFeed - 13 Jan 2016
Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals
Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals
HSMN NewsFeed - 21 Sep 2015
Sequenom Announces Appointment of Dirk van den Boom as Interim President and CEO
Sequenom Announces Appointment of Dirk van den Boom as Interim President and CEO
HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
HSMN NewsFeed - 9 Jun 2015
Healthcare Executive Noel Mijares to Join Millennium Healthcare Inc. as New CEO
Healthcare Executive Noel Mijares to Join Millennium Healthcare Inc. as New CEO
HSMN NewsFeed - 29 Apr 2015
Valeant Announces CFO Succession Plan And Additional Executive Appointment
Valeant Announces CFO Succession Plan And Additional Executive Appointment
HSMN NewsFeed - 27 Apr 2015
Synta Announces Chen Schor Named President, Chief Executive Officer and Director
Synta Announces Chen Schor Named President, Chief Executive Officer and Director
HSMN NewsFeed - 18 Feb 2015
Biodesix Builds on Investments in Sales, Reimbursement and Government Affairs Growth Strategy
Biodesix Builds on Investments in Sales, Reimbursement and Government Affairs Growth Strategy
HSMN NewsFeed - 15 Dec 2014
Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer
Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer
HSMN NewsFeed - 22 Sep 2014
Thoratec Appoints D. Keith Grossman President And Chief Executive Officer
Thoratec Appoints D. Keith Grossman President And Chief Executive Officer
HSMN NewsFeed - 26 Aug 2014
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
HSMN NewsFeed - 18 Aug 2014
Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board
Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board
HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
HSMN NewsFeed - 21 Apr 2014
ClearFlow Inc. Appoints Senior Sales Executive to North America Leadership Position
ClearFlow Inc. Appoints Senior Sales Executive to North America Leadership Position
HSMN NewsFeed - 21 Apr 2014
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
HSMN NewsFeed - 6 Feb 2014
Ultragenyx Appoints Clay Siegall, Ph.D. and Matthew Fust to Board of Directors
Ultragenyx Appoints Clay Siegall, Ph.D. and Matthew Fust to Board of Directors
HSMN NewsFeed - 9 Jan 2014
OvaScience Appoints David Stern to Executive Vice President, Global Commercial Operations
OvaScience Appoints David Stern to Executive Vice President, Global Commercial Operations
HSMN NewsFeed - 6 Jan 2014
Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations
Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations
HSMN NewsFeed - 17 Dec 2013
Pfizer Names Albert Bourla Group President, Vaccines, Oncology and Consumer Healthcare Business
Pfizer Names Albert Bourla Group President, Vaccines, Oncology and Consumer Healthcare Business
HSMN NewsFeed - 13 Sep 2013
Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
HSMN NewsFeed - 12 Aug 2013
MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
HSMN NewsFeed - 2 Aug 2013
LipoScience Appoints Robert Greczyn Interim President and Chief Executive Officer
LipoScience Appoints Robert Greczyn Interim President and Chief Executive Officer
HSMN NewsFeed - 20 Jun 2013
Orthofix Realigns Business Units to Support Future Growth Opportunities and Announces Leadership Changes
Orthofix Realigns Business Units to Support Future Growth Opportunities and Announces Leadership Changes
HSMN NewsFeed - 15 Apr 2013
David A. Dodd Appointed President & Chief Executive Officer of Aeterna Zentaris Inc.
David A. Dodd Appointed President & Chief Executive Officer of Aeterna Zentaris Inc.
HSMN NewsFeed - 14 Mar 2013
Orthofix International Appoints Brad Mason as President and Chief Executive Officer
Orthofix International Appoints Brad Mason as President and Chief Executive Officer
HSMN NewsFeed - 1 Mar 2013
Sucampo Appoints Barbara A. Munder and Maureen E. O’Connell to Board of Directors
Sucampo Appoints Barbara A. Munder and Maureen E. O’Connell to Board of Directors
HSMN NewsFeed - 19 Feb 2013
Berkley C. Nelson Joins Sharps Compliance as Senior Vice President of Sales
Berkley C. Nelson Joins Sharps Compliance as Senior Vice President of Sales
HSMN NewsFeed - 28 Nov 2012
Precision Spine(TM) Initiates New Development Effort with Stephen D. Cook, Ph.D.
Precision Spine(TM) Initiates New Development Effort with Stephen D. Cook, Ph.D.
HSMN NewsFeed - 27 Nov 2012
Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
HSMN NewsFeed - 17 Oct 2012
DelRey ENT Associates Enhances the Care and Comfort of Tonsillectomy Patients with Thermal Fusion Technology
DelRey ENT Associates Enhances the Care and Comfort of Tonsillectomy Patients with Thermal Fusion Technology
HSMN NewsFeed - 10 Sep 2012
ZELTIQ(R) Aesthetics Announces Resignation of President of Its North American Franchise
ZELTIQ(R) Aesthetics Announces Resignation of President of Its North American Franchise
HSMN NewsFeed - 28 Aug 2012
Covidien Receives FDA 510(k) Clearance for Groundbreaking iDrive(TM) Ultra Powered Stapling System
Covidien Receives FDA 510(k) Clearance for Groundbreaking iDrive(TM) Ultra Powered Stapling System
HSMN NewsFeed - 27 Aug 2012
SurModics Announces Resignation of Jeffrey Smith from the Board of Directors
SurModics Announces Resignation of Jeffrey Smith from the Board of Directors
HSMN NewsFeed - 20 Jul 2012
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis(TM) (carfilzomib) for Injection
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis(TM) (carfilzomib) for Injection
HSMN NewsFeed - 22 May 2012
Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement
Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement
HSMN NewsFeed - 1 May 2012
Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
HSMN NewsFeed - 8 Feb 2012
Stephen P. MacMillan Resigns as Chairman, President and CEO of Stryker Corporation
Stephen P. MacMillan Resigns as Chairman, President and CEO of Stryker Corporation
HSMN NewsFeed - 30 Jan 2012
Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc.
Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc.
HSMN NewsFeed - 10 Dec 2011
Transition Therapeutics Announces the Departure of Its President and Chief Financial Officer
Transition Therapeutics Announces the Departure of Its President and Chief Financial Officer
HSMN NewsFeed - 2 Dec 2011
Catalyst Pharmaceutical Partners Promotes Alicia Grande to Vice President and Chief Financial Officer
Catalyst Pharmaceutical Partners Promotes Alicia Grande to Vice President and Chief Financial Officer
HSMN NewsFeed - 4 Nov 2011
Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
HSMN NewsFeed - 3 Oct 2011
Varian Medical Systems Books $88 Million Order to Equip Proton Treatment Center
Varian Medical Systems Books $88 Million Order to Equip Proton Treatment Center
HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
HSMN NewsFeed - 21 Jul 2011
Titan Medical Inc. Enters Into Exclusive Patent License Agreement for Novel Surgical Stapler
Titan Medical Inc. Enters Into Exclusive Patent License Agreement for Novel Surgical Stapler
HSMN NewsFeed - 9 Jun 2011
Welch Allyn Appoints Hisham Hout to Senior Vice President, Europe and Middle East
Welch Allyn Appoints Hisham Hout to Senior Vice President, Europe and Middle East
HSMN NewsFeed - 23 May 2011
Elixir Medical Receives CE Mark for DESyne(TM) Novolimus Eluting Coronary Stent System
Elixir Medical Receives CE Mark for DESyne(TM) Novolimus Eluting Coronary Stent System
HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
HSMN NewsFeed - 21 Mar 2011
Regulus Therapeutics Appoints Lars Karlsson, M.D., Ph.D., VP of Immunology and Fibrosis
Regulus Therapeutics Appoints Lars Karlsson, M.D., Ph.D., VP of Immunology and Fibrosis
HSMN NewsFeed - 15 Feb 2011
Nfocus Neuromedical, Inc. Luna Aneurysm Embolization System Receives CE Mark
Nfocus Neuromedical, Inc. Luna Aneurysm Embolization System Receives CE Mark
HSMN NewsFeed - 2 Dec 2010
Regulus Therapeutics Strengthens Immunology Leadership Team with New Key Appointment
Regulus Therapeutics Strengthens Immunology Leadership Team with New Key Appointment
HSMN NewsFeed - 16 Nov 2010
Palatin Technologies Appoints Jeffrey D. Edelson, M.D., Chief Medical Officer
Palatin Technologies Appoints Jeffrey D. Edelson, M.D., Chief Medical Officer
HSMN NewsFeed - 28 Oct 2010
Sanofi-Aventis Completes $10 Million Equity Investment in Regulus Therapeutics
Sanofi-Aventis Completes $10 Million Equity Investment in Regulus Therapeutics
HSMN NewsFeed - 26 Oct 2010
Response Biomedical Corporation Announces the Resignation of Chief Operating Officer
Response Biomedical Corporation Announces the Resignation of Chief Operating Officer
HSMN NewsFeed - 19 Oct 2010
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
HSMN NewsFeed - 22 Sep 2010
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
HSMN NewsFeed - 17 Aug 2010
STAAR Surgical Expands Leadership Team to Execute Company's Growth Strategy
STAAR Surgical Expands Leadership Team to Execute Company's Growth Strategy
HSMN NewsFeed - 16 Jun 2010
Eurand Names Former Solvay Executive Jean-Louis Anspach President of U.S. Pharmaceuticals Business
Eurand Names Former Solvay Executive Jean-Louis Anspach President of U.S. Pharmaceuticals Business
HSMN NewsFeed - 19 May 2010
GenVec Announces Resignation of Mark Thornton as Senior Vice President, Product Development
GenVec Announces Resignation of Mark Thornton as Senior Vice President, Product Development
HSMN NewsFeed - 11 Feb 2010
OXiGENE Announces Restructuring to Focus Resources on Key Programs and Provides Business Update
OXiGENE Announces Restructuring to Focus Resources on Key Programs and Provides Business Update
HSMN NewsFeed - 11 Jan 2010
Regulus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., Director of Business Development
Regulus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., Director of Business Development
HSMN NewsFeed - 5 Jan 2010
Oraya Therapeutics Initiates First Ever Sham-Controlled Study of Radiation Therapy for Wet AMD
Oraya Therapeutics Initiates First Ever Sham-Controlled Study of Radiation Therapy for Wet AMD
HSMN NewsFeed - 15 Dec 2009
ViraCor-IBT Laboratories Names Dr. Mark Roberts President and Chief Executive Officer
ViraCor-IBT Laboratories Names Dr. Mark Roberts President and Chief Executive Officer
HSMN NewsFeed - 27 Oct 2009
Lumenis Receives 510(k) Clearance for the PolyScope Disposable Flexible Endoscope
Lumenis Receives 510(k) Clearance for the PolyScope Disposable Flexible Endoscope
HSMN NewsFeed - 13 Oct 2009
AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy
AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy
HSMN NewsFeed - 2 Oct 2009
The Medicines Company Announces the Resignation of Its Chief Operating Officer
The Medicines Company Announces the Resignation of Its Chief Operating Officer
HSMN NewsFeed - 17 Jul 2009
NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors
NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors
HSMN NewsFeed - 20 May 2009
Direct Flow Medical Completes First Human Use of 18F Percutaneous Aortic Valve System
Direct Flow Medical Completes First Human Use of 18F Percutaneous Aortic Valve System
HSMN NewsFeed - 19 May 2009
Endeavor Drug-Eluting Stent is First to Receive CE Mark for Treating Acute Coronary Syndrome
Endeavor Drug-Eluting Stent is First to Receive CE Mark for Treating Acute Coronary Syndrome
HSMN NewsFeed - 14 May 2009
Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
HSMN NewsFeed - 1 Apr 2009
Small Bone Innovations, Inc. Strengthens Senior Management & Announces Formation of Executive Committee
Small Bone Innovations, Inc. Strengthens Senior Management & Announces Formation of Executive Committee
HSMN NewsFeed - 31 Mar 2009
Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System
Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System
HSMN NewsFeed - 30 Mar 2009
Medtronic Receives Regulatory Approval For Endeavor Drug-Eluting Coronary Stent in Japan
Medtronic Receives Regulatory Approval For Endeavor Drug-Eluting Coronary Stent in Japan
HSMN NewsFeed - 23 Mar 2009
Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
HSMN NewsFeed - 29 Jan 2009
Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO
Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO
HSMN NewsFeed - 26 Jan 2009
CardioNet Board of Directors Appoints Randy Thurman Interim President and Chief Executive Officer
CardioNet Board of Directors Appoints Randy Thurman Interim President and Chief Executive Officer
HSMN NewsFeed - 11 Dec 2008
TomoTherapy Announces Retirement of Paul J. Reckwerdt as President and Board Member
TomoTherapy Announces Retirement of Paul J. Reckwerdt as President and Board Member
HSMN NewsFeed - 11 Dec 2008
Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
HSMN NewsFeed - 2 Dec 2008
Medtronic Launches Sprinter® Angioplasty Balloon Cathethers on Rapid Exchange
Medtronic Launches Sprinter® Angioplasty Balloon Cathethers on Rapid Exchange
HSMN NewsFeed - 12 Nov 2008
Medtronic Launches Endeavor® Sprint Drug-Eluting Stent System on Rapid Exchange in United States
Medtronic Launches Endeavor® Sprint Drug-Eluting Stent System on Rapid Exchange in United States
HSMN NewsFeed - 30 Oct 2008
Medtronic to Launch Coronary Stents and Balloon Catheters on Rapid Exchange in United States
Medtronic to Launch Coronary Stents and Balloon Catheters on Rapid Exchange in United States
HSMN NewsFeed - 13 Oct 2008
Antares Pharma Appoints Paul K. Wotton, Ph.D., as President and Chief Executive Officer
Antares Pharma Appoints Paul K. Wotton, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 6 Oct 2008
Terrence A. Noonan Named Endocare Interim President and Interim Chief Executive Officer
Terrence A. Noonan Named Endocare Interim President and Interim Chief Executive Officer
HSMN NewsFeed - 3 Oct 2008
Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
HSMN NewsFeed - 19 Sep 2008
Accuray Licenses Technology From Morphormics for Prostate Cancer Treatment Planning
Accuray Licenses Technology From Morphormics for Prostate Cancer Treatment Planning
HSMN NewsFeed - 17 Sep 2008
Nephros Appoints Ernest A. Elgin III as President and Chief Executive Officer
Nephros Appoints Ernest A. Elgin III as President and Chief Executive Officer
HSMN NewsFeed - 15 Sep 2008
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
HSMN NewsFeed - 3 Sep 2008
Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors
Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors
HSMN NewsFeed - 18 Aug 2008
Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
HSMN NewsFeed - 30 Jul 2008
Medtronic Starts U.S. Arm of Global Study Comparing Safety of Endeavor(R) and Cypher(R) Drug-Eluting Stents
Medtronic Starts U.S. Arm of Global Study Comparing Safety of Endeavor(R) and Cypher(R) Drug-Eluting Stents
HSMN NewsFeed - 17 Jul 2008
Isis Announces Appointment of Martin P. Bedigian, M.D. as Vice President and Chief Medical Officer
Isis Announces Appointment of Martin P. Bedigian, M.D. as Vice President and Chief Medical Officer
HSMN NewsFeed - 16 Jun 2008
Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
HSMN NewsFeed - 12 May 2008
Watson Pharmaceuticals Announces Appointment of Andrew L. Turner as Chairman of the Board of Directors
Watson Pharmaceuticals Announces Appointment of Andrew L. Turner as Chairman of the Board of Directors
HSMN NewsFeed - 30 Apr 2008
Titan Pharmaceuticals, Inc. Executive Chairman, Dr. Louis R. Bucalo, Retires to Pursue Other Interests
Titan Pharmaceuticals, Inc. Executive Chairman, Dr. Louis R. Bucalo, Retires to Pursue Other Interests
HSMN NewsFeed - 25 Apr 2008
FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen
FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen
HSMN NewsFeed - 24 Apr 2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
HSMN NewsFeed - 7 Apr 2008
Robert Palmisano Appointed President, Chief Executive Officer and Director of ev3 Inc.
Robert Palmisano Appointed President, Chief Executive Officer and Director of ev3 Inc.
HSMN NewsFeed - 3 Apr 2008
Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
HSMN NewsFeed - 31 Mar 2008
Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms
Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms
HSMN NewsFeed - 5 Mar 2008
Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
HSMN NewsFeed - 28 Feb 2008
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
HSMN NewsFeed - 27 Feb 2008
IsoRay Appoints New Chairman and Interim CEO and Announces Management Changes upon Incumbent Resignation
IsoRay Appoints New Chairman and Interim CEO and Announces Management Changes upon Incumbent Resignation
HSMN NewsFeed - 11 Feb 2008
Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
HSMN NewsFeed - 11 Feb 2008
Regulus Therapeutics Appoints Peter S. Linsley, Ph.D. as Chief Scientific Officer
Regulus Therapeutics Appoints Peter S. Linsley, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 1 Feb 2008
Medtronic Receives FDA Approval for Endeavor(R) Zotarolimus-Eluting Coronary Stent System
Medtronic Receives FDA Approval for Endeavor(R) Zotarolimus-Eluting Coronary Stent System
HSMN NewsFeed - 30 Jan 2008
Stephen Hill, ArQule President and CEO, to Join Solvay Pharmaceuticals, Inc. as New President and CEO
Stephen Hill, ArQule President and CEO, to Join Solvay Pharmaceuticals, Inc. as New President and CEO
HSMN NewsFeed - 23 Jan 2008
NMT Medical Announces Significant Changes to Its Clinical Trial Plans in the United States
NMT Medical Announces Significant Changes to Its Clinical Trial Plans in the United States
HSMN NewsFeed - 20 Jan 2008
James LeVoy Sorenson, World-Renowned Medical Device Inventor, Entrepreneur and Philanthropist, Dies at 86
James LeVoy Sorenson, World-Renowned Medical Device Inventor, Entrepreneur and Philanthropist, Dies at 86
HSMN NewsFeed - 17 Jan 2008
Regeneration Technologies, Tutogen Medical Announce New Name for Proposed Merged Company
Regeneration Technologies, Tutogen Medical Announce New Name for Proposed Merged Company
HSMN NewsFeed - 7 Jan 2008
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
HSMN NewsFeed - 4 Jan 2008
CONMED Announces Resignation of Company's CONMED Linvatec Subsidiary President
CONMED Announces Resignation of Company's CONMED Linvatec Subsidiary President
HSMN NewsFeed - 3 Jan 2008
IVAX Diagnostics Announces Resignation of President and Chief Executive Officer
IVAX Diagnostics Announces Resignation of President and Chief Executive Officer
HSMN NewsFeed - 27 Dec 2007
Manhattan Pharmaceuticals Names Mary C. Spellman, M.D. as Head of Dermatology and Drug Development
Manhattan Pharmaceuticals Names Mary C. Spellman, M.D. as Head of Dermatology and Drug Development
HSMN NewsFeed - 14 Dec 2007
Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
HSMN NewsFeed - 3 Dec 2007
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer
HSMN NewsFeed - 14 Nov 2007
Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
HSMN NewsFeed - 26 Oct 2007
Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors
Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors
HSMN NewsFeed - 24 Oct 2007
Safety Profile of Medtronic's Endeavor(R) Drug-Eluting Stent Affirmed in Comprehensive Data Analysis
Safety Profile of Medtronic's Endeavor(R) Drug-Eluting Stent Affirmed in Comprehensive Data Analysis
HSMN NewsFeed - 22 Oct 2007
Endeavor Clinical Program Continues to Provide Positive Safety and Efficacy Data
Endeavor Clinical Program Continues to Provide Positive Safety and Efficacy Data
HSMN NewsFeed - 10 Oct 2007
FDA Advisory Committee Recommends Medtronic's Endeavor(R) Drug-Eluting Stent for Approval
FDA Advisory Committee Recommends Medtronic's Endeavor(R) Drug-Eluting Stent for Approval
HSMN NewsFeed - 5 Oct 2007
Medtronic to Present Findings from the Comprehensive ENDEAVOR Clinical Experience to FDA Advisory Panel
Medtronic to Present Findings from the Comprehensive ENDEAVOR Clinical Experience to FDA Advisory Panel
HSMN NewsFeed - 4 Oct 2007
Dr. Martin Mackay Named President of Pfizer Global Research and Development
Dr. Martin Mackay Named President of Pfizer Global Research and Development
HSMN NewsFeed - 2 Oct 2007
Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
HSMN NewsFeed - 18 Sep 2007
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
HSMN NewsFeed - 13 Sep 2007
Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
HSMN NewsFeed - 12 Sep 2007
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent on October 10
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent on October 10
HSMN NewsFeed - 10 Sep 2007
Obagi Medical Products Reorganizes International Sales and Manufacturing/Distribution Business Units
Obagi Medical Products Reorganizes International Sales and Manufacturing/Distribution Business Units
HSMN NewsFeed - 5 Sep 2007
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
HSMN NewsFeed - 4 Sep 2007
Pioneer Surgical Technology Hires Vice President of New Business Development
Pioneer Surgical Technology Hires Vice President of New Business Development
HSMN NewsFeed - 28 Aug 2007
Cubist Pharmaceuticals Creates COO Position, Adds Scientific Advisory Board
Cubist Pharmaceuticals Creates COO Position, Adds Scientific Advisory Board
HSMN NewsFeed - 21 Aug 2007
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent in October
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent in October
Additional items found! 306
Members Archive contains
306 additional stories matching:
Endeavor
(Password required)
Endeavor
(Password required)
